Analysis of UK primary care records reveals that how much an individual's biomarker levels fluctuate over months and years provides mortality and cardiovascular risk information beyond what single blood test values show. Using Sequential Monte Carlo modeling on eight routinely measured biomarkers from General Practitioners' data, researchers found six biomarkers whose within-person variance patterns independently predicted health outcomes after accounting for average biomarker levels. This approach separated natural aging changes from shorter-term biological fluctuations and measurement errors. The finding challenges the standard medical practice of relying primarily on most recent lab values for risk assessment. Biomarker variability as a prognostic tool could represent biological system instability or loss of homeostatic control with aging. However, this remains a preprint awaiting peer review, so conclusions may change. The methodology's complexity and requirement for multiple measurements over extended periods currently limits practical clinical application. While promising for personalized medicine, implementing variability-based risk assessment would require fundamental changes to how healthcare systems collect and analyze laboratory data, moving from episodic testing toward continuous biomarker monitoring approaches.